Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anders Widmark
Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer
JAMA Oncology
Cancer Research
Oncology
Related publications
Prognostic Value of Bone Scan Index as an Imaging Biomarker in Metastatic Prostate Cancer: A Meta-Analysis
Oncotarget
Oncology
Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study/Spcg11
European urology oncology
Oncology
Radiology
Urology
Nuclear Medicine
Imaging
Surgery
The Effect of Therapeutic Anticoagulation on Overall Survival in Men Receiving First-Line Docetaxel Chemotherapy for Metastatic Castration-Resistant Prostate Cancer
Clinical Genitourinary Cancer
Oncology
Urology
A Phase 2 Trial of Abiraterone Acetate Without Glucocorticoids for Men With Metastatic Castration-Resistant Prostate Cancer
Cancer
Cancer Research
Oncology
Predictive Factors of Response and Overall Survival in Patients With Castration-Resistant Metastatic Prostate Cancer Undergoing177Lu-Psma Therapy
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Prediction of Overall Survival for Patients With Metastatic Castration-Resistant Prostate Cancer: Development of a Prognostic Model Through a Crowdsourced Challenge With Open Clinical Trial Data
The Lancet Oncology
Oncology
Docetaxel and Dasatinib or Placebo in Men With Metastatic Castration-Resistant Prostate Cancer (READY): A Randomised, Double-Blind Phase 3 Trial
The Lancet Oncology
Oncology
Overall Survival and Second Primary Malignancies in Men With Metastatic Prostate Cancer
PLoS ONE
Multidisciplinary
Evaluating Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer With Imaging
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
